Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis

Diseases of the Esophagus

Volumn 21, Issue 4, 2008, Pages 288-297

  Ogawa, R ^a   Ishiguro, Hideyuki ^a   Kuwabara, Y ^a   Kimura, M ^a   Mitsui, A ^a   Mori, Y ^a   Mori, R ^a   Tomoda, K ^a   Katada, T ^a   Harada, K ^a   Fujii, Y ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Esophageal cancer; Microarray; Radiosensitivity

Indexed keywords

ABC TRANSPORTER; ACETYLSEROTONIN METHYLTRANSFERASE; ADRENOMEDULLIN; CALCIUM BINDING PROTEIN; CARBONYL REDUCTASE; COMPLEMENT COMPONENT C2; COMPLEMENTARY DNA; CYTOKERATIN 5; DESMOCOLLIN; DNA; FATTY ACID BINDING PROTEIN; FIBRONECTIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE TRANSFERASE M3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN; INTERLEUKIN 8; LEUCINE ZIPPER PROTEIN; MEMBRANE PROTEIN; METALLOTHIONEIN I; NUCLEOTIDE BINDING PROTEIN; REPLICATION FACTOR A; RNA; S PHASE KINASE ASSOCIATED PROTEIN; STEFIN A; STROMELYSIN 2; TRANSALDOLASE; TROPOMYOSIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; CANCER RADIOTHERAPY; CELL SURVIVAL; CLONOGENIC ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TREATMENT OUTCOME; TUMOR GROWTH; UNINDEXED SEQUENCE; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 43449125649     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00759.x     Document Type: Article

References (23)

1. Xiao Z F, Yang Z Y, Liang J et al. Value of radiotherapy after radical surgery for esophageal carcinoma. a report of 495 patients. Ann Thorac Surg 2003; 75: 331-6.
2. Bosset J F, Lorchel F, Mantion G. Neoadjuvant treatment of early stage squamous cell carcinoma of the esophagus. Dis Esophagus 2002; 15: 117-20.
3. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002; 359: 1727-33.
4. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
5. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
6. Kitahara O, Furukawa Y, Tanaka T et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 2001; 61: 3544-9.
7. Zhao K L, Shi X H, Jiang G L et al. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: A phase III randomized study. Int J Radiat Oncol Biol Phys 2005; 62: 1014-20.
8. Burns T F, El-Deiry W S. Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation. Cancer Biol Ther 2003; 2: 431-43.
9. Jeong J, Hong S J, Ju Y J et al. Temporal cDNA microarray analysis of gene expression in human hepatocellular carcinoma upon radiation exposure. Oncol Report 2006; 15: 33-48.
10. Cho E I, Kowalski D P, Sasaki C T, Haffty B G. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy. Laryngoscope 2004; 114: 2001-8.
11. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993; 119: 441-9.
12. Ono K. Prediction of radiosensitivity by micronucleus assay. Gan No Rinsho 1989; 35: 1566-71.
13. Hanna E, Shrieve D C, Ratanatharathorn V et al. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res 2001; 61: 2376-80.
14. Teyssier F, Bay J O, Dionet C, Verrelle P. Cell cycle regulation after exposure to ionizing radiation. Bull Cancer 1999; 86: 345-57.
15. Kim S H, Kim J H, Djordjevic B. Effects of x-irradiation on RNA and protein synthesis in HeLa cells. Radiat Res 1970; 42: 577-89.
16. Barone R, Borson-Chazot F, Valkema R et al. Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC. relevance of kidney Volume and dose rate in finding a dose-effect relationship. J Nucl Med 2005; 46: 99S-106S.
17. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. H2AX. The histone guardian of the genome. DNA Repair (Amst) 2004; 3: 959-67.
18. Macgregor P F. Gene expression in cancer. The application of microarrays. Expert Rev Mol Diagn 2003; 3: 185-200.
19. Gomes X V, Wold M S. Functional domains of the 70-kilodalton subunit of human replication protein A. Biochemistry 1996; 35: 10558-68.
20. Nagasaki K, Schem C, von Kaisenberg C et al. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 2003; 105: 454-8.
21. Nakada Y, Taniura H, Uetsuki T, Inazawa J, Yoshikawa K. The human chromosomal gene for necdin, a neuronal growth suppressor, in the Prader-Willi syndrome deletion region. Gene 1998; 213: 65-72.
22. Binz S K, Sheehan A M, Wold M S. Replication protein A phosphorylation and the cellular response to DNA damage. DNA Repair (Amst) 2004; 3: 1015-24.
23. Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T, Yamaguchi K. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett 1999; 140: 227-34.